Navigation Links
Atrium Innovations Announces Management Changes
Date:9/10/2007

QUEBEC CITY, QC, Sept. 10 /PRNewswire-FirstCall/ - Mr. Pierre Fitzgibbon, President and Chief Executive Officer of Atrium Innovations Inc. ("Atrium" or the "Company", TSX: ATB) today announced changes to the management structure of Atrium. These changes follow the decision by Mr. Richard Bordeleau, President of the Health & Nutrition Division, to resign his position in order to pursue news challenges. However, Mr. Bordeleau will continue to work with the Company as an external consultant on special projects.

"Richard played an important role in the development and growth of Atrium over the last few years. His talent and passion have greatly contributed to the success of the Company. Richard, after personal reflection, has decided to take on new challenges and we wish him the best. We are also very happy that we will be able to benefit from Richard's experience in his role as a consultant for Atrium", added Mr. Fitzgibbon.

Subsequent to Mr. Bordeleau's departure, Dr. Serge Yelle, Atrium's current Vice-President, Business Development is appointed Executive Vice-President, Health & Nutrition Division. Dr. Yelle's mandate will be to supervise the operations of the division. "Serge has demonstrated his vast know-how over the past few years in the development of Atrium not only in the identification of target companies, but also in the integration of acquired companies. He has done this most notably with Douglas Laboratories and more recently with Mucos. In his new position, Serge will exercise a greater leadership role in the development of the Company and will use his many talents that will be positive for the future of Atrium", stated Mr. Fitzgibbon.

Also, Mr. Jocelyn Harvey, Vice-President, Mergers & Acquisitions, will assume certain business development functions that were performed by Dr. Yelle. These functions include the identification and the qualification of acquisition targets.

About Atrium

Atrium Innovations Inc. is a recognized leading developer, manufacturer and marketer of science-based products for the cosmetics, pharmaceutical, chemical and nutrition industries. The Company focuses primarily on growing segments of the health and personal care markets which are benefiting from the trends towards healthy living and the ageing of the population. Atrium markets a broad portfolio of active ingredients, specialty chemicals and health and nutrition finished products through its highly specialized sales and marketing network in more than 50 countries, primarily in North America, Europe and Asia. Atrium has over 600 employees. Additional information about Atrium is available on its Web site at http://www.atrium-innov.com.

Cautionary Note and Forward-Looking Statements

This press release contains certain forward-looking statements with respect to the Company. These forward-looking statements, by their nature, necessarily involve risks and uncertainties that could cause actual results to differ materially from those contemplated by these forward-looking statements. The Company considers the assumptions on which these forward-looking statements are based to be reasonable, but cautions the reader that these assumptions regarding future events, many of which are beyond its control, may ultimately prove to be incorrect since they are subject to risks and uncertainties that affect the Company. For additional information with respect to these and other factors, see the Company's quarterly and annual filings with the Canadian securities commissions. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, other than as required by law.


'/>"/>
SOURCE ATRIUM INNOVATIONS INC.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Pilot fund brings capital to Eau Claire area innovations
2. Wisconsin state agencies commended for digital innovations
3. Oshkoshs Pierce Security Vehicle Ranked in top 100 Technological Innovations for 2003
4. Speaker announces business members of IT Task Force
5. Doyle announces technology tax credits for Berbee
6. Doyle announces new energy, global warming policies
7. Doyle announces $80M renewable energy strategy
8. GE announces first installation of Discovery VCT
9. UWM announces winners of RGI awards
10. Third Wave announces two senior management appointments
11. Mirus announces new method for making antibodies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... ... May 06, 2016 , ... Crucial Life Sciences ... Version 4.1, greatly improves performance of the platform. In particular, Version 4.1 boosts ... volumes of data to be collected on a per patient basis. Clinical Studio ...
(Date:5/5/2016)... ... May 05, 2016 , ... American Process, Inc. (API) announced ... Patent Nos. 9,322,133 and 9,322,134, to API and its affiliated companies for BioPlus® ... hydrophobic nanocellulose compositions. In addition to these patents and U.S. Patent No. ...
(Date:5/4/2016)... ... May 05, 2016 , ... CereScan, the ... National Stroke Association during National Stroke Awareness Month in May. An infographic ... throughout the month. CereScan will donate $1 up to a maximum of ...
(Date:5/4/2016)... , May 4, 2016  Bayer today announced ... compound Stivarga ® (regorafenib) tablets for the ... has met its primary endpoint of a statistically ... RESORCE, evaluated the efficacy and safety of regorafenib ... after treatment with sorafenib. The safety and tolerability ...
Breaking Biology Technology:
(Date:3/14/2016)... 14, 2016 http://www.apimages.com ) ... --> - Renvoi : image disponible via AP ... --> --> DERMALOG, le leader ... nouveaux lecteurs d,empreintes digitales pour l,enregistrement des réfugiés ... utilisé pour produire des cartes d,identité aux réfugiés. ...
(Date:3/10/2016)... 10, 2016   Unisys Corporation (NYSE: UIS ... (CBP) is testing its biometric identity solution at the ... to help identify certain non-U.S. citizens leaving the country. ... designed to help determine the efficiency and accuracy of using ... and will run until May 2016. --> ...
(Date:3/8/2016)... , March 8, 2016   Valencell , ... today announced it has secured $11M in Series ... Tech, a new venture fund being launched by ... participation from existing investors TDF Ventures and WSJ ... to continue its triple-digit growth and accelerate its ...
Breaking Biology News(10 mins):